Announced today that Bruker Corporation and Agilent Systems.

Supply Varian, Inc.. Bruker to acquire certain product lines of Varian Related StoriesEMBL researchers use mass spectrometry data to analyze effects of cancer drugsExperts to highlight fresh diagnostic items, tools to identify heart attacks at 2015 AACC Annual MeetingNew data analysis system reveals major flaw in GC-MS processVarian, Inc. announced today that Bruker Corporation and Agilent Systems, Inc. have entered into a definitive asset purchase agreement pursuant to which Bruker will acquire specific products of Varian.Related StoriesSausages With Antioxidants From Berries TO AVOID CancerMeat-rich diet may boost kidney cancer riskStudy displays uncommon HER2 missense mutations usually do not spread breasts cancer on the ownProfessor Tiganis says it had been know that PTKs are associated with several types of intense cancers, including colon, lung and breast cancers, but they have finally discovered that PTKs likewise have an important part to play as tumor cells develop and mutate to be potentially more intense tumours. Tiganis says the even more there is known about how exactly tumours develop means the more capable we are to avoid their growth later on.